Literature DB >> 7524976

Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classification and the study of cervix cancer aetiology.

F Smedts1, F Ramaekers, M Link, L Lauerova, S Troyanovsky, C Schijf, G P Vooijs.   

Abstract

We investigated the expression of keratin subtypes 7, 8, 10, 13, 14, 17, 18 and 19 in the normal cervix, in cervical intraepithelial neoplasia (CIN) lesions and in cervical carcinomas, using a selected panel of monoclonal keratin antibodies, reactive with routinely processed, formalin fixed paraffin embedded tissue fragments. The reaction patterns derived for each keratin antibody were compared with known expression patterns of the various epithelia, previously examined in frozen tissues. Although the reactivity of the antibodies was generally acceptable, considerable modifications to the manufacturers' staining instructions were often necessary. For some antibodies, which were previously thought to be reactive with fresh frozen tissue only, we developed staining protocols rendering them reactive with routinely processed material. As with previous findings in frozen sections we observed increasing expression of keratins 7, 8, 17, 18 and 19 with increasing grade of CIN. In cervical carcinomas the differences in keratin detectability between the main categories were more pronounced than in frozen sections, probably due to fixation and processing. For routine pathology, keratin phenotyping of cervical lesions may be of value in classification. The fact that keratin 7 was detected for the first time in reserve cells, and that this keratin was also found to be expressed in a considerable number of CIN lesions and cervical carcinomas supports the suggestion that reserve cells are a common progenitor cell for these lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524976     DOI: 10.1007/bf00230351

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Cytokeratin expression in squamous metaplasia of the human uterine cervix.

Authors:  O Gigi-Leitner; B Geiger; R Levy; B Czernobilsky
Journal:  Differentiation       Date:  1986       Impact factor: 3.880

2.  Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia.

Authors:  F Smedts; F Ramaekers; H Robben; M Pruszczynski; G van Muijen; B Lane; I Leigh; P Vooijs
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

Review 3.  Use of keratin antibodies in tumor diagnosis.

Authors:  E B Lane; C M Alexander
Journal:  Semin Cancer Biol       Date:  1990-06       Impact factor: 15.707

4.  Expression of keratin 13 in human epithelial neoplasms.

Authors:  M J Malecha; M Miettinen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Cytokeratins of normal epithelia and some neoplasms of the female genital tract.

Authors:  R Moll; R Levy; B Czernobilsky; P Hohlweg-Majert; G Dallenbach-Hellweg; W W Franke
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

6.  Adenocarcinoma of the cervix treated with radiation alone: prognostic significance of S-100 protein and vimentin immunostaining.

Authors:  K Oka; T Nakano; T Arai
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

7.  The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas.

Authors:  J H Baars; J L De Ruijter; F Smedts; C C Van Niekerk; L G Poels; C A Seldenrijk; F C Ramaekers
Journal:  Am J Clin Pathol       Date:  1994-03       Impact factor: 2.493

Review 8.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07

9.  Antibody markers of basal cells in complex epithelia.

Authors:  P E Purkis; J B Steel; I C Mackenzie; W B Nathrath; I M Leigh; E B Lane
Journal:  J Cell Sci       Date:  1990-09       Impact factor: 5.285

10.  Patterns of expression of keratin 17 in human epithelia: dependency on cell position.

Authors:  S M Troyanovsky; V I Guelstein; T A Tchipysheva; V A Krutovskikh; G A Bannikov
Journal:  J Cell Sci       Date:  1989-07       Impact factor: 5.285

View more
  6 in total

1.  Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma.

Authors:  P Maddox; P Sasieni; A Szarewski; M Anderson; A Hanby
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.

Authors:  C Carrilho; L Cirnes; M Alberto; L Buane; N Mendes; L David
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

3.  Modeling and validating three dimensional human normal cervix and cervical cancer tissues in vitro.

Authors:  Anna Karolina Zuk; Xuesong Wen; Stephen Dilworth; Dong Li; Lucy Ghali
Journal:  J Biomed Res       Date:  2017-01-19

4.  Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.

Authors:  Hojung Lee; Hyekyung Lee; Yong Kyun Cho
Journal:  Diagn Pathol       Date:  2017-02-17       Impact factor: 2.644

5.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

6.  Correlation of P16 (Ink4a) and CK17 to HPV (16E6+18E6) in Premalignant and Malignant Lesions of Uterine Cervix: A Clinicopathologic Study.

Authors:  Mohammed K Chaloob; Alaa G Hussein; Ban J Qasim
Journal:  Iran J Pathol       Date:  2016
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.